Eugene Scott Crist bought $30k of ARBE
director at Arbe Robotics Ltd.. 50,000 shares at an average of $0.61, traded Sep 28, 2026, filed Oct 6, 2026.
Score components
- +15RoleDirector
- +5Trade size$30k at market
- +3Relative to holdingsHoldings up 5%
- +18Price context8% above the 52-week low; 78% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-26-107326, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | POpen-market purchase Ordinary Shares | +50,000 | $0.61 | $30k | 1,014,182 | 8 d ago |
Related signals
Other insiders at Arbe Robotics Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | ARBEbuy Arbe Robotics Ltd. | Eugene Scott Crist director | $30 50 shares | +0% | |
| 13Weak | Arbe Robotics Ltd. | Noam Arkind Chief Technology Officer | $254k 337,300 shares | -22% | |
| 1Weak | Arbe Robotics Ltd. | Noam Arkind Chief Technology Officer | $40k 62,700 shares | -4% | |
| 13Weak | Arbe Robotics Ltd. | Noam Arkind Chief Technology Officer | $233k 200,000 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.